Abstract
Bronchodilators, corticosteroids, and antibiotics are still key elements for treating chronic obstructive pulmonary disease in the 2019 Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommendations and this is due in part to our current inability to discover new drugs capable of decisively influencing the course of the disease. However, in recent years, information has been produced that, if used correctly, can allow us to improve the use of the available therapies.
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference58 articles.
1. Chronic obstructive pulmonary disease (COPD)
2. An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations?;M Cazzola;Expert Rev Respir Med.,2018
3. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; [updated 2019]
4. Pharmacology and therapeutics of bronchodilators.;M Cazzola;Pharmacol Rev.,2012
5. Bronchodilators, receptors and cross-talk: Together is better?;R Panettieri;Postgrad Med.,2015
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献